Keep in touch with the latest that’s happening at Rockpointe.
If you are a member of the press and would like more information, you may contact us here.

CME = Quality

CME Updates on Metastatic Pancreatic Cancer Guidelines Live Webinar Series and Webcourse

2022-08-16

Metastatic pancreatic cancer is a serious malignancy that, with limited treatment options and poor outcomes, poses a growing challenge for oncologists. Increasing in incidence, it is projected to be the second-leading cause of cancer-related death before 2030. Though targeted therapies are available for a small subset of patients, advances in targeted therapies for other cancer […]

CME = Quality

Clinical Education Alliance Accelerates Primary Care Education Opportunities Through Acquisition of Rockpointe

2022-07-26

Merger expands CEA’s outreach to community healthcare professionals in under-served areas Clinical Education Alliance (CEA) Holdings today announced the acquisition of Rockpointe Corporation, a premier healthcare education company and provider of accredited continuing medical education (CE) programs and publisher of Policy and Medicine. This acquisition supports CEA’s focus on high-science therapeutic areas while allowing an expansion into primary […]

CME = Quality

CME-MOC Webinar Series to Update Clinicians on Latest in NASH (non-alcoholic steatohepatitis)  Diagnosis and Management

2022-03-31

CME-MOC Webinar Series to Update Clinicians on Latest in NASH (non-alcoholic steatohepatitis)  Diagnosis and Management NASH (non-alcoholic steatohepatitis) is a liver disorder characterized by accumulation of fat in the liver and liver scarring. It occurs most commonly in patients with obesity and is often associated with diabetes. Without treatment, NASH can progress rapidly to cirrhosis, […]

CME = Quality

CME webinar primes PCPs on advances in Alzheimer’s disease diagnosis and treatment

2022-03-17

CME webinar primes PCPs on advances in Alzheimer’s disease diagnosis and treatment More than 6 million people in the U.S. are estimated to be living with Alzheimer’s disease (AD), and that number is expected to double by 2050. With a scarcity of Alzheimer’s specialists across the country, diagnosis and care commonly fall to primary care […]

CME = Quality

CME webinar guides clinicians on individualizing HER2-positive breast cancer treatment

2022-03-07

CME webinar guides clinicians on individualizing HER2-positive breast cancer treatment Despite significant improvement in the treatment of HER2-positive metastatic breast cancer in recent years, breast cancer remains a leading cause of death among women in the United States. The American Cancer Society estimates that approximately 287,850 women will be diagnosed with invasive breast cancer in […]

CME = Quality

CME Updates on Metastatic Pancreatic Cancer Guidelines Live Webinar Series and Webcourse

2022-08-16

Metastatic pancreatic cancer is a serious malignancy that, with limited treatment options and poor outcomes, poses a growing challenge for oncologists. Increasing in incidence, it is projected to be the second-leading cause of cancer-related death before 2030. Though targeted therapies are available for a small subset of patients, advances in targeted therapies for other cancer […]

CME = Quality

CME-MOC Webinar Series to Update Clinicians on Latest in NASH (non-alcoholic steatohepatitis)  Diagnosis and Management

2022-03-31

CME-MOC Webinar Series to Update Clinicians on Latest in NASH (non-alcoholic steatohepatitis)  Diagnosis and Management NASH (non-alcoholic steatohepatitis) is a liver disorder characterized by accumulation of fat in the liver and liver scarring. It occurs most commonly in patients with obesity and is often associated with diabetes. Without treatment, NASH can progress rapidly to cirrhosis, […]

CME = Quality

CME webinar primes PCPs on advances in Alzheimer’s disease diagnosis and treatment

2022-03-17

CME webinar primes PCPs on advances in Alzheimer’s disease diagnosis and treatment More than 6 million people in the U.S. are estimated to be living with Alzheimer’s disease (AD), and that number is expected to double by 2050. With a scarcity of Alzheimer’s specialists across the country, diagnosis and care commonly fall to primary care […]

CME = Quality

CME webinar guides clinicians on individualizing HER2-positive breast cancer treatment

2022-03-07

CME webinar guides clinicians on individualizing HER2-positive breast cancer treatment Despite significant improvement in the treatment of HER2-positive metastatic breast cancer in recent years, breast cancer remains a leading cause of death among women in the United States. The American Cancer Society estimates that approximately 287,850 women will be diagnosed with invasive breast cancer in […]

CME = Quality

Online Course to Update Allergists and Dermatologists on Latest in Atopic Dermatitis Management

2022-03-07

Online Course to Update Allergists and Dermatologists on Latest in Atopic Dermatitis Management Atopic dermatitis (AD) is a chronic, relapsing inflammatory condition that is estimated to afflict more than 26 million people in the United States. If left uncontrolled, AD can have a significant impact on patient health and quality of life (QoL), and approximately […]